Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol
Infection, thrombosis, and catheter dislodgment are well-recognized potential complications of chronic intravenous prostanoid therapy for pulmonary arterial hypertension. As long-term outcomes of pulmonary hypertension patients improve, novel adverse events are likely to arise. We describe the sudde...
Main Authors: | Barbara L. LeVarge, Anica C. Law, Blanche Murphy |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-12-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045893217748054 |
Similar Items
-
Prostanoid therapies in the management of pulmonary arterial hypertension
by: LeVarge BL
Published: (2015-03-01) -
Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
by: Shaadi Abughazaleh, et al.
Published: (2020-01-01) -
Stress Cardiomyopathy Precipitated by Withdrawal of Epoprostenol
by: William J. Gionfriddo, MD, et al.
Published: (2020-02-01) -
Epoprostenol sodium for treatment of pulmonary arterial hypertension
by: Saito Y, et al.
Published: (2015-05-01) -
Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension
by: Mazen Al-Qadi, et al.
Published: (2021-03-01)